Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies [PDF]
The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis.
Cristina Regueiro +10 more
doaj +6 more sources
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. [PDF]
Carbamylation is a post-translational modification that mostly affects proteins with low turnover, such as dermal proteins. Carbamylated proteins accumulate in skin in an age-dependent manner, contributing to tissue alterations.
Elvira Favoino +6 more
doaj +6 more sources
Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients [PDF]
Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics.
Cristina Regueiro +9 more
doaj +6 more sources
Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis [PDF]
Background Rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein (anti-CarP) antibodies are rheumatoid arthritis (RA)-associated autoantibodies. Besides their presence in human serum, anti-CarP antibodies have
Marije K. Verheul +4 more
doaj +6 more sources
The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients [PDF]
Background Anti-carbamylated protein (anti-CarP) antibodies have recently been reported to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and diagnostic properties.
Myrthe A. M. van Delft +8 more
doaj +6 more sources
Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients. [PDF]
Patients with rheumatoid arthritis (RA) have an increased mortality rate that is associated with the presence of RA-specific autoantibodies in many studies.
Laura Vidal-Bralo +7 more
doaj +5 more sources
Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. [PDF]
Anti-carbamylated protein (anti-CarP) antibodies are detected in RA patients. Fetal calf serum is used as an antigen source in anti-CarP ELISA, and the precise target antigens have not been found. We aimed to identify the target antigens of anti-CarP antibodies.Western blotting of anti-CarP antibodies was conducted.
Nakabo S +16 more
europepmc +5 more sources
Anti-Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap-Mediated Bone Loss in Rheumatoid Arthritis. [PDF]
Objective Carbamylation, a nonenzymatic post‐translational modification, contributes to rheumatoid arthritis (RA) pathogenesis. Anti‐carbamylated protein antibodies (anti‐CarP) occur in around 50% of patients with RA and associate with greater joint damage. Neutrophil extracellular traps (NETs) are a major source of carbamylated autoantigens. We sought
Nakabo S +9 more
europepmc +2 more sources
Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid arthritis (RA) and may present before disease onset.
Ashraf H Mohamed +6 more
doaj +2 more sources
Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis [PDF]
Several autoantibodies against proteins with post-translational modifications have been detected in patients with rheumatoid arthritis (RA) and are called anti-modified protein antibodies (AMPAs).
Shuichiro Nakabo
doaj +3 more sources

